, ICO Information Centre on HPV and Cancer (HPV Information Centre): Human Papillomavirus and, pp.12-18, 2014.
The causal relation between human papillomavirus and cervical cancer, J Clin Pathol, vol.55, issue.4, pp.244-65, 2002. ,
Human papillomavirus and cervical cancer, Clin Microbiol Rev, vol.16, issue.1, pp.1-17, 2003. ,
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice, Lancet Oncol, vol.12, issue.7, pp.663-72, 2011. ,
Overview of the European and north American studies on HPV testing in primary cervical cancer screening, Int J Cancer, vol.119, issue.5, pp.1095-101, 2006. ,
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial, Lancet, vol.370, issue.9601, pp.1764-72, 2007. ,
Understanding HPV tests and their appropriate applications, Cytopathology, vol.24, issue.5, pp.289-308, 2013. ,
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older, Int J Cancer, vol.124, issue.3, pp.516-536, 2009. ,
World Health Organization guidelines for treatment of cervical intraepithelial neoplasia 23 and screen-and-treat strategies to prevent cervical cancer, Int J Gynaecol Obstet, vol.132, issue.3, pp.252-260, 2016. ,
Molecular analysis of human Papillomavirus detected among women positive for cervical lesions by visual inspection with acetic acid/Lugol's iodine (VIA/VILI) in Libreville, Gabon. Infect Agent Cancer, vol.11, issue.1, p.50, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02002416
The use of general primers GP5 and GP6 elongated at their 3? ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR, J Gen virology, vol.76, pp.1057-62, 1995. ,
Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia, J Natl Cancer Inst, vol.85, issue.12, pp.958-64, 1993. ,
Degenerate and nested PCR: a highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts, J Clin Microbiol, vol.37, issue.11, pp.3545-55, 1999. ,
PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets, J Clinical Virol, vol.30, issue.4, pp.302-310, 2004. ,
Comparative evaluation of the Abbott RealTime high risk HPV test and INNO-LiPA HPV genotyping extra test for detecting and identifying human papillomaviruses in archival tissue specimens of head and neck cancers, Acta Dermatovenerol Alp Pannonica Adriat, vol.21, issue.4, pp.73-78, 2012. ,
Vrtacnik Bokal E. Threeyear longitudinal data on the clinical performance of the Abbott RealTime high risk HPV test in a cervical cancer screening setting, J Clin Virol, 2015. ,
Principles and analytical performance of Abbott RealTime high risk HPV test, J Clin Virol, vol.45, issue.1, pp.13-20, 2009. ,
Rapid 16S rRNA nextgeneration sequencing of polymicrobial clinical samples for diagnosis of complex bacterial infections, PLoS One, vol.8, issue.5, p.65226, 2013. ,
Next-generation DNA sequencing, Nat Biotechnol, vol.26, issue.10, pp.1135-1180, 2008. ,
Multiplatform comparison of molecular oncology tests performed on cytology specimens and formalinfixed, paraffin-embedded tissue, Cancer Cytopathol, vol.123, issue.1, pp.30-39, 2015. ,
Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination, Am J Epidemiol, vol.178, issue.4, pp.625-659, 2013. ,
Evaluation of human papillomavirus type replacement postvaccination must account for diagnostic artifacts: masking of HPV52 by HPV16 in anogenital specimens, Cancer Epidemiol Biomark Prev, vol.24, issue.1, pp.286-90, 2015. ,
In vitro assessment of the effect of vaccine-targeted human papillomavirus (HPV) depletion on detection of non-vaccine HPV types: implications for postvaccine surveillance studies, J Virol Methods, vol.214, pp.10-14, 2015. ,
ONCOGENIC HUMAN PAPILLOMAVIRUSES: high-risk human Papillomaviruses: towards a better understanding of the mechanisms of viral transformation, latency and immune-escape, Open Virol J, vol.6, pp.160-162, 2012. ,
Performance of the Abbott RealTime high-risk HPV test in women with abnormal cervical cytology smears, J Med Virol, vol.82, issue.7, pp.1186-91, 2010. ,
Chapter 10: new dimensions in cervical cancer screening, Vaccine, vol.24, 2006. ,
Detection and genotyping of human papillomavirus by five assays according to cytologic results, J Virol Methods, vol.187, issue.1, pp.79-84, 2013. ,
Comparison of the clinical performances of the AdvanSure HPV screening real-time PCR, the Abbott real-time high-risk HPV test, and the hybrid capture high-risk HPV DNA test for cervical cancer screening, J Virol Methods, vol.205, pp.57-60, 2014. ,
Clinical validation of the Abbott RealTime high risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening, J Clin Microbiol, vol.51, issue.7, pp.2409-2419, 2013. ,
The impact of liquid-based cytology in decreasing the incidence of cervical cancer, Rev Obstet Gynecol, vol.4, issue.1, pp.2-11, 2011. ,